SUZANNE JARDINE: Open Payments
NPI 1306390380 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 29 payments from 13 companies in 2025. Trend: 2023 $326 · 2024 $665 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $217 |
| Novo Nordisk Inc | 3 | $46 |
| Antares Pharma, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Acella Pharmaceuticals, LLC | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $28 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: UBRELVY, QULIPTA, XYOSTED, Symbravo, NURTEC ODT, NP Thyroid 60, VOQUEZNA, Veozah.
Industry payments across ID — which companies pay providers there.
